AcclaimIP-ad

Match Document Document Title
US20140348909 PHARMACEUTICAL COMPOSITIONS OF LURASIDONE  
The present invention relates to pharmaceutical compositions of lurasidone or salts thereof. In particular, the invention relates to pharmaceutical compositions of lurasidone or salts thereof with...
US20140227353 PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF HELICOBACTER PYLORI  
Single oral solid dosage form comprising an immediate release first dosage composition having at least two antibiotic agents and a delayed release second dosage composition having a proton pump...
US20100008982 NON-COVALENT COMPLEXES OF BIOACTIVE AGENTS WITH STARCH FOR ORAL DELIVERY  
The present invention relates to particles comprising non-covalent complexes which comprise starch and an active agent and dry compositions containing such particles for the oral delivery of the...
US20080124387 METHODS AND FORMULATIONS FOR ENHANCING THE ABSORPTION AND DECREASING THE ABSORPTION VARIABILITY OF ORALLY ADMINISTERED DRUGS, VITAMINS AND NUTRIENTS  
A method and composition of preparing bioavailable hydrophobic, poorly water soluble drugs. It uses for example, lecithin, sterol, and solvent; mixing and then the solvent driven off; the ratios...
US20070071807 CAPSULE-TYPE DRUG-RELEASING DEVICE AND CAPSULE-TYPE DRUG-RELEASING DEVICE SYSTEM  
A capsule-type drug-releasing device is capable of freely controlling the release and stoppage of a drug and causing neither the back flow of contents of a stomach, an intestine, or the like nor...
US20070128266 Pharmaceutical or dietary compositions based on short-chain fatty acids and complex sugars, for intestinal disorders  
Pharmaceutical and/or dietary compositions for supplying energy and eutrophication factors to the large intestine to improve its functionality and prevent the appearance of pathological conditions...
US20060115524 Method for preparation of an agglomerate using melt agglomeration  
Melt agglomeration for the preparation of an agglomerated material is performed us-ing a vehicle that can be melted at a suitable temperature, an active compound and silicon dioxide as filler....
US20130302413 POLYNUCLEAR MICROCAPSULES  
A process is disclosed for preparing polynuclear microcapsules by polymerizing an alkoxysilane at the oil/water interface of a multiple phase emulsion to form a suspension of polynuclear...
US20050118254 Microemulsion preconcentrate  
A microemulsion preconcentrate is provided, which comprises an active component, an oil, a surfactant, and a hydrophilic solvent selected from the group consisting of propylene glycol diacetate,...
US20090117163 Composition and Method for the Application of Human Synthetic Pheromones Using Substance Slowly Releasing Technological Bio Capsule in form of Drops in Clothing, Underwear, Jewels and Like  
The invention regards a composition for the application of human synthetic pheromones in clothing, underwear, jewels, and like, comprising at least three positive human substances, e.g....
US20050064027 Bioadhesive drug delivery system with enhanced gastric retention  
Bioadhesive macrosphere delivery systems (“BDDS”) having prolonged gastric retention time due to bioadhesion rather than physical density or size are described. In general, the macrospheres have...
US20150225439 Dendrimer Scaffolds for Pharmaceutical Use  
This invention relates to certain dendrimer compounds. In particular, this invention relates to novel dendrimer compounds that can be elaborated to give increasingly large and complex compounds....
US20070281000 Stable formulation comprising moisture sensitive drug/s and manufacturing procedure thereof  
The present invention provides stable pharmaceutical compositions comprising moisture sensitive drugs, in particular an angiotensin converting enzyme (ACE) inhibitor such as Cilazapril, as the...
US20060280788 Delivery and formulations of mast cell stabilizers  
Diseases of the colon are treated by oral ingestion of a unit dosage form containing a mast cell stabilizer as an active agent. The dosage form is targeted for delivery of the active agent to the...
US20110159082 PHARMACEUTICAL COMPOSITION CONTAINING FENOFIBRATE AND METHOD FOR THE PREPARATION THEREOF  
The invention concerns a pharmaceutical composition containing micronized fenofibrate, a surfactant and a binding cellulose derivative, as solubilizing adjuvant, preferably...
US20080063606 Pulmonary delivery of aminoglycoside  
A dispersible powder composition comprises aminoglycoside for delivery to the lungs. The composition is effective to provide a therapeutically effective therapy via administration of less than 6...
US20120021048 Combination Dosage Compositions Comprising a Cholesterol-Lowering Agent, a Renin-Angiotensin System Inhibitor, an Antioxidant Agent and an Antiplatelet Agent for Treatment and Prevention of Cardiovascular Disease  
The present invention is in the fields of medicine, pharmaceuticals, nutraceuticals and cardiology. The invention provides compositions comprising a statin, an inhibitor of the angiotensin...
US20080118552 Finely Divided Composition Containing Poorly Water Soluble Substance  
A composition containing a poorly water soluble substance of the present invention is a composition having a median diameter of not more than 1 μm, comprising (i) a poorly water soluble substance...
US20100285121 Capsule Formulation  
The present invention provides the following capsule preparation, which is superior in dissolution property and the like of a pharmaceutically active ingredient and contains liquid and solid...
US20060034910 Pharmaceutical composition for extended release of phenytoin sodium  
The present invention provides an oral extended release solid pharmaceutical composition of phenytoin sodium or its pharmaceutically acceptable derivative thereof and the process of manufacturing...
US20140199381 CORE-SHELL MICROSPHERES  
The specification describes a substance comprising a plurality of microparticles. The microparticles comprise a core comprising a first polymer and a shell surrounding said core and comprising the...
US20150079160 NON-IMPLANTABLE MEDICAL DEVICE COATED WITH NANO-CARRIERS FOR DELIVERING ONE OR MORE DRUGS TO A BODY SITE  
A drug-delivering medical device for delivering a drug to a target site in a human body is disclosed. The drug-delivering medical device may have a hydrophilic surface, with one or more portions...
US20080317841 Pharmaceutical Composition Containing Coated, Floating Particles  
A dosage form exhibiting delayed transit time through the GI tract. The dosage form comprises a plurality of buoyant particles, each comprising an inner drug-containing core, an intermediate layer...
US20140322309 ALPHA-AMINOAMIDINE POLYMERS AND USES THEREOF  
α-Aminoamidine polymers and methods of preparing a-aminoamidine polymers by reacting by reacting one or more amines with one or more isocyanides and one or more aldehydes are described. Methods of...
US20120128764 CONTROLLED-RELEASE COMPOSITIONS COMPRISING A PROTON PUMP INHIBITOR  
The present invention relates to pharmaceutical compositions, and methods of preparing such compositions, comprising one or more populations of controlled-release particles comprising one or more...
US20080089934 PROCESS FOR MAKING GEL FILMS  
The present invention is directed to a process for making homogeneous, thermoreversible gel films comprising the steps of: (i) heating, hydrating, mixing, solubilizing, and, optionally,...
US20140017306 STABLE PHARMACEUTICAL COMPOSITION AND METHODS OF USING SAME  
The present invention relates to, inter alia, pharmaceutical compositions comprising a polyunsaturated fatty acid and to methods of using the same to treat or prevent cardiovascular-related diseases.
US20130171251 STABLE PHARMACEUTICAL COMPOSITION AND METHODS OF USING SAME  
The present invention relates to, inter alia, pharmaceutical compositions comprising a polyunsaturated fatty acid and to methods of using the same to treat or prevent cardiovascular-related diseases.
US20130156852 STABLE PHARMACEUTICAL COMPOSITION AND METHODS OF USING SAME  
The present invention relates to, inter alia, pharmaceutical compositions comprising a polyunsaturated fatty acid and to methods of using the same to treat or prevent cardiovascular-related diseases.
US20130011472 STABLE PHARMACEUTICAL COMPOSITION AND METHODS OF USING SAME  
The present invention relates to, inter alia, pharmaceutical compositions comprising a polyunsaturated fatty acid and to methods of using the same to treat or prevent cardiovascular-related diseases.
US20130011471 STABLE PHARMACEUTICAL COMPOSITION AND METHODS OF USING SAME  
The present invention relates to, inter alia, pharmaceutical compositions comprising a polyunsaturated fatty acid and to methods of using the same to treat or prevent cardiovascular-related diseases.
US20130004572 STABLE PHARMACEUTICAL COMPOSITION AND METHODS OF USING SAME  
The present invention relates to, inter alia, pharmaceutical compositions comprising a polyunsaturated fatty acid and to methods of using the same to treat or prevent cardiovascular-related diseases.
US20120225120 STABLE PHARMACEUTICAL COMPOSITION AND METHODS OF USING SAME  
The present invention relates to, inter alia, pharmaceutical compositions comprising a polyunsaturated fatty acid and to methods of using the same to treat or prevent cardiovascular-related diseases.
US20120100208 STABLE PHARMACEUTICAL COMPOSITION AND METHODS OF USING SAME  
The present invention relates to, inter alia, pharmaceutical compositions comprising a polyunsaturated fatty acid and to methods of using the same to treat or prevent cardiovascular-related diseases.
US20050152965 Coated drug delivery formulations  
The invention relates generally to methods of making formulations for delivering biological agents to a patient. In one aspect, proliposomal drug-delivery systems for medicaments are provided. In...
US20090208567 SUBSTANCE-CONTAINING CARBON NANOHORN COMPOSITE HAVING POLYAMINE PLUG AND PROCESS FOR PRODUCING THE SAME  
The present invention provides: a carbon nanohorn composite including a carbon nanohorn, a substance encapsulated in the carbon nanohorn, and a polyamine adsorbed by chemical reaction firmly to a...
US20050112190 Dosage form for controlled release of an active agent formulation  
The present invention is directed to a dosage form configured to provide the controlled release of an active agent formulation. A dosage form according to the present invention includes a...
US20100291198 COMPOSITIONS OF PHYTOSTEROLS WITH ENHANCED BIOAVAILABILITY  
A method for preparing porous microparticles containing phytosterol, by preparing a homogeneous melt of phytosterol and a partially water soluble component, cooling the melt to obtain an amorphous...
US20050196437 Hard capsules  
The present invention pertains to a blend of a physically induced starch hydrolysate, a plasticizer, and a gelling agent. Such blend produces an excellent film with low brittleness. Further,...
US20130004569 ORAL ANTIMICROBIAL PHARMACEUTICAL COMPOSITIONS  
The present invention relates to oral pharmaceutical compositions with controlled and/or programmed release containing at least one active ingredient having antimicrobial and/or anti-infectious...
US20100086586 Pharmaceutical Composition  
A pharmaceutical composition comprising eplerenone having a D90 particle size of between 15-25 microns and further comprising one or more pharmaceutically acceptable excipients.
US20090098199 METHODS OF TREATING GASTROINTESTINAL DISORDERS INDEPENDENT OF THE INTAKE OF FOOD  
The present invention relates to a method of treating a gastrointestinal disorder by administering to a patient in need of treatment thereof a pharmaceutical composition, wherein said...
US20070224248 METHOD AND COMPOSITIONS FOR TREATING ACNE  
A method and composition for treating acne. The present invention involves treatment of this medical condition with an oral administration of a mixture comprised of inorganic nickel compound(s)...
US20130302415 Pharmaceutical Composition  
A pharmaceutical composition comprising efavirenz wherein the efavirenz is in the form of nanoparticles is disclosed.
US20130171248 ORAL FORMULATION FOR DELIVERY OF POORLY ABSORBED DRUGS  
A composition for oral delivery of a poorly absorbed drug is disclosed. The composition includes the drug, an enhancer for increasing absorption of the drug through the intestinal mucosa, a...
US20050271594 Abuse resistent pharmaceutical composition  
An abuse-resistant pharmaceutical composition includes an oily substance, at least one active ingredient having abuse potential and a capsule. The active ingredient is mixed in the oily substance....
US20070166372 Preparation of solid coprecipitates of amorphous valsartan  
A novel coprecipitate of amorphous valsartan with a pharmaceutically acceptable carrier, e.g. polyvinylpyrolidone (PVP), crosslinked-polyvinylpyrolidone, polyvinylpyrolidone vinyl acetate...
US20080118554 Pharmaceutical compositions comprising a combination of piperidinoalkanol and decongestant  
A pharmaceutical composition comprising a first therapeutic agent and a second therapeutic agent is described. A plurality of particles comprising (i) an interior comprising the second therapeutic...
US20050152967 Dynamic variable release  
The present invention relates to novel mixed release pharmaceutical formulations that include a expectorant available for immediate release and a decongestant for extended release that provide for...
US20150209294 PHARMACEUTICAL COMPOSITION AND PROCESS  
There is provided a formulation comprising N-(2-chloro-6-methylbenzoyl)-4-[(2,6-dichlorobenzoyl)amino]- L-phenylalanine-2(diethylamino)ethyl ester and poloxamer 188 which is manufactured by a hot...